HydroxycarbamideDel (5q)-positive myelodysplastic syndrome: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1647卷 / 1期
关键词：
D O I：
10.1007/s40278-017-28848-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：156 / 156
相关论文
共 50 条
  • [31] Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?
    Duerr, Donat
    Siciliano, Raffaele Daniele
    Hummel, Yvonne
    O'Meara, Alix
    Hirschi, Anita
    Burkhard, Roger
    Honegger, Hanspeter
    ANNALS OF HEMATOLOGY, 2010, 89 (01) : 105 - 106
  • [32] Two different del(5q) clones in a patient with myelodysplastic syndrome
    Braulke, Friederike
    Schanz, Julie
    Steffens, Rainer
    Liehr, Thomas
    Manvelyan, Marina
    Chudoba, Ilse
    Haase, Detlef
    LEUKEMIA & LYMPHOMA, 2011, 52 (09) : 1811 - 1814
  • [33] Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes
    Giagounidis, Aristoteles A. N.
    SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 312 - 322
  • [34] Cyclophosphamide5q deletion myelodysplastic syndrome: case report
    Reactions Weekly, 2017, 1647 (1) : 101 - 101
  • [35] Incidence and Biologic Features of 5q Deletion and 5q-Syndrome in Myelodysplastic Syndrome in Korea; According to Reclassification of Myelodysplastic Syndrome by WHO 2008.
    Lee, Hye Ryun
    Hong, Dae Sik
    Zang, Dae Young
    Lee, Hong Ghi
    Yoon, Hwi-Joong
    Kim, Hyeoung-Joon
    Kim, Inho
    Ahn, Jae-Sook
    Lee, Jong-Seok
    Cheong, June-Won
    Lee, Kyung-A
    Bang, Soo-Mee
    Park, Su Yon
    Yun, Yeo Min
    Min, Yoo-Hong
    Lee, You Kyung
    Lee, Dong Soon
    BLOOD, 2009, 114 (22) : 1087 - 1087
  • [36] Paediatric Myelodysplastic Syndrome With 5Q Deletion in a Patient With Hyperleukocytosis and Significant Lymphadenopathy
    Coopasamy, K.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S458 - S459
  • [37] Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion
    Duong, Vu H.
    Komrokji, Rami S.
    List, Alan F.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (02) : 105 - 116
  • [38] Myelodysplastic syndromes 5q deletion in childhood
    Iriani, A.
    LEUKEMIA RESEARCH, 2013, 37 : S93 - S93
  • [39] Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer
    B L Ebert
    Leukemia, 2009, 23 : 1252 - 1256
  • [40] Del(5q) myelodysplastic syndrome combined with pure red cell aplasia
    Park, Joowon
    BLOOD RESEARCH, 2018, 53 (02) : 104 - 104
12345